| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000027595 |
| Receipt No. | R000031626 |
| Official scientific title of the study | Demonstration test of the multimodal homeostasis evaluation systems |
| Date of disclosure of the study information | 2017/06/01 |
| Last modified on | 2017/09/20 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Demonstration test of the multimodal homeostasis evaluation systems | |
| Title of the study (Brief title) | Demonstration test of the multimodal homeostasis evaluation systems | |
| Region |
|
|
| Condition | ||
| Condition | Healthy Adults | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Evaluate the multimodal homeostasis evaluation systems using tangerine juice as a test food. |
| Basic objectives2 | Others |
| Basic objectives -Others | Evaluate the correlation with existing measurement items and verify the usefulness of this system. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Multimodal homeostasis evaluation systems |
| Key secondary outcomes | Self-awareness questionnaire, physical examination, antioxidant / anti-inflammatory marker, transcriptome analysis, salivary marker |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Tangerine juice 125 ml/day for 4 weeks | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document
2.Healthy Japanese who is 20 years old or more and under 70 years old |
|||
| Key exclusion criteria | 1.Persons who have chronic illness and are receiving medication
2.Persons who are allergic to the test food 3.Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam 4.Persons who are pregnant, planning or hoping to be pregnant during the study period, breastfeeding 5.Persons who were judged as inappropriate for subjects by the principal investigator |
|||
| Target sample size | 6 | |||
| Research contact person | |
| Name of lead principal investigator | Toshihiko Osawa |
| Organization | Aichi Gakuin University |
| Division name | Department of Health and Nutrition |
| Address | 12 Araike, Iwasaki-cho, Nisshin-shi, Aichi, Japan |
| TEL | 0561-73-1111 |
| osawat@dpc.aichi-gakuin.ac.jp | |
| Public contact | |
| Name of contact person | Hirohito Ishikawa |
| Organization | Healthcare Systems Co., Ltd. |
| Division name | Research and Development |
| Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN |
| TEL | 03-6809-2722 |
| Homepage URL | |
| ishikawa@hc-sys.jp | |
| Sponsor | |
| Institute | Aichi Gakuin University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Cabinet Office, Government of Japan |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Healthcare Systems Co., Ltd.
Control of innate immunity TRA Hamamatsu Photonics K.K. |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031626 |